“We had been stunned and intensely upset to be taught at the moment that Fernando Tatis Jr. examined constructive for a performance-enhancing substance in violation of Main League Baseball’s Joint Prevention and Remedy Program and subsequently obtained an 80-game suspension with out pay,” the Padres mentioned in a press release Friday. “We totally assist the Program and are hopeful that Fernando will be taught from this expertise.”
Tatis, who has missed the Padres’ first 114 video games due to a wrist harm, had lately began a rehabilitation stint within the minors and had appeared poised to quickly be a part of the Padres’ lineup. In 2021, Tatis hit a league-leading 42 dwelling runs and had 97 RBIs whereas ending third within the voting for Nationwide League Most Helpful Participant.
Following the announcement of his suspension, the MLB Gamers Affiliation launched a press release on behalf of Tatis.
“It seems that I inadvertently took a medicine to deal with ringworm that contained Clostebol,” Tatis mentioned. “I ought to have used the sources accessible to me as a way to make sure that no banned substances had been in what I took. I failed to take action.”
Tatis apologized to the Padres’ group, the league and followers in his assertion, calling what he did “my mistake.”
“I’ve no excuse for my error, and I’d by no means do something to cheat or disrespect this recreation I like,” Tatis mentioned.
“I’ve taken numerous drug assessments all through my skilled profession, together with on March 29, 2022, all of which have returned unfavourable outcomes till this check.
“I’m utterly devastated. There may be nowhere else on this planet I’d slightly be than on the sphere competing with my teammates. After initially interesting the suspension, I’ve realized that my mistake was the reason for this outcome, and for that cause I’ve determined to start out serving my suspension instantly. I look ahead to rejoining my teammates on the sphere in 2023.”
In 2021, Tatis reportedly signed a 14-year contract price $340 million.
CNN’s Jill Martin contributed to this report.